Credit rating
Company information
About PHARMAERO ApS
PHARMAERO ApS (CVR number: 32827942) is a company from GLADSAXE. The company recorded a gross profit of -18.6 kDKK in 2023. The operating profit was -18.6 kDKK, while net earnings were -20.1 kDKK. The profitability of the company measured by Return on Assets (ROA) was -21.3 %, which can be considered poor and Return on Equity (ROE) was -32.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 64.2 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PHARMAERO ApS's liquidity measured by quick ratio was 2.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 29.00 | 149.00 | |||
Gross profit | 29.00 | 149.00 | -1 266.00 | - 638.19 | -18.61 |
EBIT | -14 001.00 | -2 095.00 | -1 266.00 | - 638.19 | -18.61 |
Net earnings | -12 231.00 | -1 773.00 | -1 297.00 | - 650.59 | -20.07 |
Shareholders equity total | 6 586.00 | 4 813.00 | 3 516.00 | 71.99 | 51.92 |
Balance sheet total (assets) | 7 209.00 | 5 260.00 | 3 534.00 | 93.53 | 80.88 |
Net debt | -4 422.00 | -4 631.00 | -3 517.00 | -79.26 | -61.92 |
Profitability | |||||
EBIT-% | -48279.3 % | -1406.0 % | |||
ROA | -99.8 % | -33.6 % | -28.8 % | -35.2 % | -21.3 % |
ROE | -183.5 % | -31.1 % | -31.1 % | -36.3 % | -32.4 % |
ROI | -210.0 % | -36.8 % | -30.4 % | -35.5 % | -24.1 % |
Economic value added (EVA) | -11 764.77 | -1 853.43 | -1 275.15 | - 638.14 | -17.67 |
Solvency | |||||
Equity ratio | 91.4 % | 91.5 % | 99.5 % | 77.0 % | 64.2 % |
Gearing | 16.0 % | 36.5 % | |||
Relative net indebtedness % | -13100.0 % | -2808.1 % | |||
Liquidity | |||||
Quick ratio | 11.6 | 11.8 | 196.3 | 4.3 | 2.8 |
Current ratio | 11.6 | 11.8 | 196.3 | 4.3 | 2.8 |
Cash and cash equivalents | 4 422.00 | 4 631.00 | 3 517.00 | 90.81 | 80.88 |
Capital use efficiency | |||||
Trade debtors turnover (days) | 365.0 | ||||
Net working capital % | 22710.3 % | 3230.2 % | |||
Credit risk | |||||
Credit rating | C | B | B | C | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.